In what marks a positive development for patient access to psychedelic therapies in the US, the American Medical Association has released the language of its first-ever...
Psychedelic Medicine Investment Fund Negev Capital is aiming to innovate mental healthcare in Europe by providing funding to companies on the cutting edge of psychedelic research.
For the first time, the U.S.
Brazilian indigenous spiritual leader, Chief iIxiwaka Biraci Yawanawa, will be giving a keynote address on June 23 on the ‘Importance of Protecting Ayahuasca Biocultures From Commercialization,...
Global investment firm Psych Capital has agreed to acquire 100% of the issued share capital of Shortwave Pharma Inc.,
A new Ethics Council was launched at the Inaugural Summit of The World’s Leaders in Psychedelics that will work to guide industry standards and best practices.
PSYCH Symposium: London 2023 is returning on 6 July at the iconic British Museum to explore the latest challenges and opportunities in the field of psychedelic...
With a rise in clinical research and trials into the use of psychedelic therapies for mental health, and with a number of countries changing regulations around...
The world’s first postgraduate course on psychedelics has been launched at the University of Exeter – an interdisciplinary programme for healthcare workers, therapists and others to...
Filament Health and PharmAla Biotech Holdings Inc.
